Ovation Fertility Austin physician attends the 2016 JP Morgan Healthcare Conference
Dr. Kaylen Silverberg was recently invited to attend the JP Morgan Healthcare Conference in San Francisco.
This meeting, sometimes called the Super Bowl of Biotech, was held from January 11-13, 2016. The invitation extended to Dr. Silverberg highlights his place of prominence, and that of Ovation Fertility, in the global medical community.
The invitation-only conference, sponsored by JPMorgan Chase & Co., is in its 34th year and was attended by over 10,000 healthcare professionals and investment bankers. Over 500 companies involved in every aspect of healthcare were also in attendance, including Illumina and EMD Serono – 2 of the many companies representing the infertility space. The purpose of the conference is to allow both emerging and established healthcare companies to present updates on their performance as well as introduce new technologies to the marketplace.
Dr. Kaylen Silverberg Represents Ovation Fertility
Dr. Silverberg wore two hats as an attendee – representing both Texas Fertility Center, where he serves as Medical Director, and Ovation Fertility, where he serves on the Board of Directors. Throughout the meeting, he networked with emerging companies to evaluate their technologies in order to determine whether or not they would enhance the scope of patient services delivered by Texas Fertility Center and Ovation Fertility.
“Attending this exclusive conference was an invaluable experience for the Ovation Fertility family of physicians and IVF labs,” said Dr. Silverberg. “Being invited to the conference is not only an excellent way to learn about and explore the current medical technology landscape, it is also an honor.”
Emerging technologies are of special interest to Dr. Silverberg, as his practice provides highly technical diagnostic and treatment services ranging from PGS for in vitro fertilization to ICSI for male factor infertility.
As usual, this year’s conference focused on all areas of medicine, with special attention being paid to the financial and investment strengths of emerging medical companies. This was especially important this year in light of the recent market fluctuation seen throughout all industries on Wall Street.
Dr. Kaylen Silverberg is a board certified fertility specialist, and a co-founder of the Texas Fertility Center. He serves as the medical director of Texas Fertility Center, Ovation Fertility Austin and San Antonio IVF. Dr. Silverberg focuses on ovulation induction for in vitro fertilization; complex endoscopic treatment of endometriosis, fibroids, pelvic adhesions and tubal disease; male factor infertility and protocol development for the cost-effective diagnosis and treatment of infertility. For more information about Dr. Silverberg, visit his online media kit. http://txfertility.com/about-tfc/kaylen-silverberg-media-kit/